|
|
 |
In focus
|
|
|
Call for applications: Kidney International® Editor-in-Chief
|
|
ISN invites applications for Editor-in-Chief (EIC) of Kidney International®. The EIC will shape the journal’s editorial vision, uphold rigorous peer-review standards, and lead a global editorial team advancing kidney science and practice. Applications open September 2025 and close November 3, 2025.
|
|
|
|
|
| |
|
|
|
Stand out and avoid pitfalls: Tips for abstract submitters
|
|
“WCN is designed to promote ‘bedside to research and back’ networking opportunities with a global impact,” says Alessia Fornoni, co-chair of the WCN Abstract Working Group. Her fellow co-chair, Bianca Davidson, adds, “It is excellent exposure of your work. I met my current collaborators through abstracts at WCN.”
|
|
|
|
|
|
|
|
|
|
WCN’26 plenary: Dennis Lo on diagnostic breakthroughs with liquid biopsy
|
|
Dennis Lo, Li Ka Shing professor of medicine at the Chinese University of Hong Kong, will deliver a WCN’26 plenary on liquid biopsy — a technique with promise for detecting transplant rejection, tracking CKD progression, and advancing precision care in kidney cancers.
|
|
|
|
|
|
|
|
|
Global Trials Focus on the CONFIDENCE trial: Dual therapy shows promise for CKD and diabetes
|
|
In people with chronic kidney disease (CKD) and type 2 diabetes, finerenone and empagliflozin reduced albuminuria more effectively than either drug alone.
|
|
|
|
|
|
|
|